{
  "DOI": "10.1038/s41431-023-01448-z",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-023-01448-z",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eBRCA1-associated protein-1 (BAP1) is a recognised tumour suppressor gene. Germline \u003cjats:italic\u003eBAP1\u003c/jats:italic\u003e pathogenic/likely pathogenic variants are associated with predisposition to multiple tumours, including uveal melanoma, malignant pleural and peritoneal mesothelioma, renal cell carcinoma and specific non-malignant neoplasms of the skin, as part of the autosomal dominant \u003cjats:italic\u003eBAP1\u003c/jats:italic\u003e-tumour predisposition syndrome. The overall lifetime risk for \u003cjats:italic\u003eBAP1\u003c/jats:italic\u003e carriers to develop at least one \u003cjats:italic\u003eBAP1\u003c/jats:italic\u003e-associated tumour is up to 85%, although due to ascertainment bias, current estimates of risk are likely to be overestimated. As for many rare cancer predisposition syndromes, there is limited scientific evidence to support the utility of surveillance and, therefore, management recommendations for \u003cjats:italic\u003eBAP1\u003c/jats:italic\u003e carriers are based on expert opinion. To date, European recommendations for \u003cjats:italic\u003eBAP1\u003c/jats:italic\u003e carriers have not been published but are necessary due to the emerging phenotype of this recently described syndrome and increased identification of \u003cjats:italic\u003eBAP1\u003c/jats:italic\u003e carriers via large gene panels or tumour sequencing. To address this, the Clinical Guideline Working Group of the CanGene-CanVar project in the United Kingdom invited European collaborators to collaborate to develop guidelines to harmonize surveillance programmes within Europe. Recommendations with respect to \u003cjats:italic\u003eBAP1\u003c/jats:italic\u003e testing and surveillance were achieved following literature review and Delphi survey completed by a core group and an extended expert group of 34 European specialists including Geneticists, Ophthalmologists, Oncologists, Dermatologists and Pathologists. It is recognised that these largely evidence-based but pragmatic recommendations will evolve over time as further data from research collaborations informs the phenotypic spectrum and surveillance outcomes.\u003c/jats:p\u003e",
  "alternative-id": [
    "1448"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "26 April 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "22 June 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "1 August 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "22 August 2023"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "The authors declare no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Lalloo",
      "given": "Fiona",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Kulkarni",
      "given": "Anju",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Chau",
      "given": "Cindy",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-5351-1870",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Nielsen",
      "given": "Maartje",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sheaff",
      "given": "Michael",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Steele",
      "given": "Jeremy",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van Doorn",
      "given": "Remco",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wadt",
      "given": "Karin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hamill",
      "given": "Monica",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-3487-9749",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Torr",
      "given": "Beth",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tischkowitz",
      "given": "Marc",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ahmed",
      "given": "Munaza",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bajalica-Lagercrantz",
      "given": "Svetlana",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Blatnik",
      "given": "Ana",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Brunet",
      "given": "Joan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cleaver",
      "given": "Ruth",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Colas",
      "given": "Chrystelle",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Dabir",
      "given": "Tabib",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Evans",
      "given": "D. Gareth",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Feshtali",
      "given": "Shirin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ghiorzo",
      "given": "Paola",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Graversen",
      "given": "Lise",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Griewank",
      "given": "Klaus",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Helgadottir",
      "given": "Hildur",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jewell",
      "given": "Rosalyn",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kohut",
      "given": "Kelly",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lorentzen",
      "given": "Henrik",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Massi",
      "given": "Daniela",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Missotten",
      "given": "Guy",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Murray",
      "given": "Alex",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Murray",
      "given": "Jennie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Nadal",
      "given": "Ernest",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ong",
      "given": "Kai Ren",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Piulats",
      "given": "Josep M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Puig",
      "given": "Susana",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rajan",
      "given": "Neil",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ribero",
      "given": "Simone",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Salle",
      "given": "Galateau",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Teul√©",
      "given": "Alexandre",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tham",
      "given": "Emma",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van Paassen",
      "given": "Barbara",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "De Putter",
      "given": "Robin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Verdijk",
      "given": "Robert",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wagner",
      "given": "Anja",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Woodward",
      "given": "Emma R.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-3303-8713",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Hanson",
      "given": "Helen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "name": "Delphi respondents",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        8,
        22
      ]
    ],
    "date-time": "2023-08-22T07:02:42Z",
    "timestamp": 1692687762000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        11,
        2
      ]
    ],
    "date-time": "2023-11-02T00:04:36Z",
    "timestamp": 1698883476000
  },
  "funder": [
    {
      "DOI": "10.13039/501100000289",
      "award": [
        "C61296/A27223",
        "C61296/A27223",
        "C61296/A27223"
      ],
      "doi-asserted-by": "publisher",
      "name": "Cancer Research UK"
    },
    {
      "DOI": "10.13039/501100000272",
      "award": [
        "NIHR203312"
      ],
      "doi-asserted-by": "publisher",
      "name": "DH | National Institute for Health Research"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        21
      ]
    ],
    "date-time": "2024-04-21T15:27:24Z",
    "timestamp": 1713713244954
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "11",
  "issued": {
    "date-parts": [
      [
        2023,
        8,
        22
      ]
    ]
  },
  "journal-issue": {
    "issue": "11",
    "published-print": {
      "date-parts": [
        [
          2023,
          11
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            8,
            22
          ]
        ],
        "date-time": "2023-08-22T00:00:00Z",
        "timestamp": 1692662400000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            8,
            22
          ]
        ],
        "date-time": "2023-08-22T00:00:00Z",
        "timestamp": 1692662400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-023-01448-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-023-01448-z",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-023-01448-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1261-1269",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2023,
        8,
        22
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        8,
        22
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2023,
        11
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1158/0008-5472.CAN-08-0365",
      "author": "KH Ventii",
      "doi-asserted-by": "publisher",
      "first-page": "6953",
      "journal-title": "Cancer Res",
      "key": "1448_CR1",
      "unstructured": "Ventii KH, Devi NS, Friedrich KL, Chernova TA, Tighiouart M, Van Meir EG, et al. BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. Cancer Res. 2008;68:6953‚Äì62.",
      "volume": "68",
      "year": "2008"
    },
    {
      "DOI": "10.1093/jnci/djy171",
      "author": "S Walpole",
      "doi-asserted-by": "publisher",
      "first-page": "1328",
      "journal-title": "J Natl Cancer Inst",
      "key": "1448_CR2",
      "unstructured": "Walpole S, Pritchard AL, Cebulla CM, Pilarski R, stautberg M, Davidorf FH, et al. Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide. J Natl Cancer Inst. 2018;110:1328‚Äì41.",
      "volume": "110",
      "year": "2018"
    },
    {
      "DOI": "10.1002/gcc.22129",
      "author": "R Pilarski",
      "doi-asserted-by": "publisher",
      "first-page": "177",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "1448_CR3",
      "unstructured": "Pilarski R, Cebulla CM, Massengill JB, Rai K, Rich T, Strong L, et al. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases. Genes Chromosomes Cancer. 2014;53:177‚Äì82.",
      "volume": "53",
      "year": "2014"
    },
    {
      "DOI": "10.3390/cancers11081114",
      "author": "C Chau",
      "doi-asserted-by": "publisher",
      "first-page": "1114",
      "journal-title": "Cancers (Basel)",
      "key": "1448_CR4",
      "unstructured": "Chau C, van Doorn R, van Poppelen NM, van der Stoep N, Mensenkamp AR, Sijmons RH, et al. Families with BAP1-tumor predisposition syndrome in The Netherlands: path to identification and a proposal for genetic screening guidelines. Cancers (Basel). 2019;11:1114.",
      "volume": "11",
      "year": "2019"
    },
    {
      "DOI": "10.1111/cge.12630",
      "author": "K Rai",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "journal-title": "Clin Genet",
      "key": "1448_CR5",
      "unstructured": "Rai K, Pilarski R, Cebulla CM, Abdel-Rahman MH. Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases. Clin Genet. 2016;89:285‚Äì94.",
      "volume": "89",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ejca.2017.12.022",
      "author": "P Star",
      "doi-asserted-by": "publisher",
      "first-page": "48",
      "journal-title": "Eur J Cancer",
      "key": "1448_CR6",
      "unstructured": "Star P, Goodwin A, Kapoor R, Conway RM, Long GV, Scolyer RA, et al. Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy. Eur J Cancer. 2018;92:48‚Äì53.",
      "volume": "92",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41431-020-0651-7",
      "author": "M Tischkowitz",
      "doi-asserted-by": "publisher",
      "first-page": "1387",
      "journal-title": "Eur J Hum Genet",
      "key": "1448_CR7",
      "unstructured": "Tischkowitz M, Colas C, Pouwels S, Hoogerbrugge N, PHTS Guideline Development Group, european Reference Network GENTURIS. Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome. Eur J Hum Genet. 2020;28:1387‚Äì93.",
      "volume": "28",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.jclinepi.2013.12.002",
      "author": "IR Diamond",
      "doi-asserted-by": "publisher",
      "first-page": "401",
      "journal-title": "J Clin Epidemiol",
      "key": "1448_CR8",
      "unstructured": "Diamond IR, grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67:401‚Äì9.",
      "volume": "67",
      "year": "2014"
    },
    {
      "DOI": "10.1002/gcc.22473",
      "author": "O Cabaret",
      "doi-asserted-by": "publisher",
      "first-page": "691",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "1448_CR9",
      "unstructured": "Cabaret O, Perron E, Bressac-de Paillerets B, Soufir N, de la Fouchardi√®re A. Occurrence of BAP1 germline mutations in cutaneous melanocytic tumors with loss of BAP1-expression: a pilot study. Genes Chromosomes Cancer. 2017;56:691‚Äì4.",
      "volume": "56",
      "year": "2017"
    },
    {
      "DOI": "10.1186/s12885-019-6226-8",
      "author": "BC Soares De S√°",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "BMC Cancer",
      "key": "1448_CR10",
      "unstructured": "Soares De S√° BC, de Mecedo MP, Torrezan GT, Braga JCT, Fidalgo F, Moredo LF, et al. BAP1 tumor predisposition syndrome case report: Pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy. BMC Cancer. 2019;19:1‚Äì8.",
      "volume": "19",
      "year": "2019"
    },
    {
      "DOI": "10.1093/neuonc/nox094",
      "author": "GM Shankar",
      "doi-asserted-by": "publisher",
      "first-page": "535",
      "journal-title": "Neuro Oncol",
      "key": "1448_CR11",
      "unstructured": "Shankar GM, Abedalthagafi M, Vaubel RA, Merrill PH, Nayyar A, Gill CM, et al. Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro Oncol. 2017;19:535‚Äì45.",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1038/ng.2813",
      "author": "Y Jiao",
      "doi-asserted-by": "publisher",
      "first-page": "1470",
      "journal-title": "Nat Genet",
      "key": "1448_CR12",
      "unstructured": "Jiao Y, Pawlik TM, Anders RA, Selaru FM, Streppel MM, Lucas DJ, et al. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet. 2013;45:1470‚Äì3.",
      "volume": "45",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.cancergen.2020.10.001",
      "doi-asserted-by": "publisher",
      "key": "1448_CR13",
      "unstructured": "Brandi G, Deserti M, Palloni, A, turchetti, D, Zuntini, R, Pedica, F et al. Intrahepatic cholangiocarcinoma development in a patient with a novel Bap1 germline mutation and low exposure to asbestos. Cancer Genet. 2020. https://doi.org/10.1016/j.cancergen.2020.10.001."
    },
    {
      "DOI": "10.1093/neuonc/nox094",
      "author": "GM Shankar",
      "doi-asserted-by": "publisher",
      "first-page": "1447",
      "journal-title": "Neuro Oncol",
      "key": "1448_CR14",
      "unstructured": "Shankar GM, Santagata S. BAP1 mutations in high-grade meningioma: implications for patient care. Neuro Oncol. 2017;19:1447‚Äì56.",
      "volume": "19",
      "year": "2017"
    },
    {
      "author": "SJ O‚ÄôShea",
      "first-page": "717",
      "journal-title": "Hum Mol Genet",
      "key": "1448_CR15",
      "unstructured": "O‚ÄôShea SJ, Robles-Espinoza CD, McLellan L, Harrigan J, Jacq X, Hewinson J, et al. A population-based analysis of germline BAP1 mutations in melanoma. Hum Mol Genet. 2017;26:717‚Äì28.",
      "volume": "26",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ophtha.2016.01.008",
      "author": "JA Turunen",
      "doi-asserted-by": "publisher",
      "first-page": "1112",
      "journal-title": "Ophthalmology",
      "key": "1448_CR16",
      "unstructured": "Turunen JA, Markkinen S, Wilska R, Saarinen S, Raivio V, T√§ll M, et al. BAP1 germline mutations in Finnish patients with uveal melanoma. Ophthalmology. 2016;123:1112‚Äì7.",
      "volume": "123",
      "year": "2016"
    },
    {
      "DOI": "10.1002/gcc.22218",
      "author": "M Betti",
      "doi-asserted-by": "publisher",
      "first-page": "51",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "1448_CR17",
      "unstructured": "Betti M, Casalone E, Ferrante D, Romanelli A, Grosso F, Guarrera S, et al. Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area. Genes Chromosomes Cancer. 2015;54:51‚Äì62.",
      "volume": "54",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pone.0122662",
      "author": "KAW Wadt",
      "doi-asserted-by": "publisher",
      "first-page": "e0122662",
      "journal-title": "PLoS One",
      "key": "1448_CR18",
      "unstructured": "Wadt KAW, Aoude LG, Krogh L, sunde L, Bojesen A, Gr√∏nskov K, et al. Molecular characterization of melanoma cases in Denmark suspected of genetic predisposition. PLoS One. 2015;10:e0122662.",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1093/hmg/ddz076",
      "author": "P Repo",
      "doi-asserted-by": "publisher",
      "first-page": "2415",
      "journal-title": "Hum Mol Genet",
      "key": "1448_CR19",
      "unstructured": "Repo P, J√§rvinen RS, J√§ntii JE, Markkinen S, T√§ll M, Raivio V, et al. Population-based analysis of BAP1 germline variations in patients with uveal melanoma. Hum Mol Genet. 2019;28:2415‚Äì26.",
      "volume": "28",
      "year": "2019"
    },
    {
      "DOI": "10.1200/JCO.2018.78.5204",
      "author": "V Panou",
      "doi-asserted-by": "publisher",
      "first-page": "2863",
      "journal-title": "J Clin Oncol",
      "key": "1448_CR20",
      "unstructured": "Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, et al. Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma. J Clin Oncol. 2018;36:2863‚Äì71.",
      "volume": "36",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.ajhg.2013.04.012",
      "author": "T Popova",
      "doi-asserted-by": "publisher",
      "first-page": "974",
      "journal-title": "Am J Hum Genet",
      "key": "1448_CR21",
      "unstructured": "Popova T, Herdert L, Jacquemin V, Gad S, Caux-Moncoutier V, Dubois-d‚ÄôEnghien C, et al. Germline BAP1 mutations predispose to renal cell carcinomas. Am J Hum Genet. 2013;92:974‚Äì80.",
      "volume": "92",
      "year": "2013"
    },
    {
      "DOI": "10.1371/journal.pone.0215725",
      "author": "MB Christensen",
      "doi-asserted-by": "publisher",
      "first-page": "e0215725",
      "journal-title": "PLoS One",
      "key": "1448_CR22",
      "unstructured": "Christensen MB, Wadt K, Jensen UB, Lautrup CK, Bojesen A, Krogh LN, et al. Exploring the hereditary background of renal cancer in Denmark. PLoS One. 2019;14:e0215725.",
      "volume": "14",
      "year": "2019"
    },
    {
      "DOI": "10.1001/jamaoncol.2018.1986",
      "author": "MI Carlo",
      "doi-asserted-by": "publisher",
      "first-page": "1228",
      "journal-title": "JAMA Oncol",
      "key": "1448_CR23",
      "unstructured": "Carlo MI, Mukherjee S, Mandelker D, vijal J, Kemel Y, Zhang L, et al. Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma. JAMA Oncol. 2018;4:1228‚Äì35.",
      "volume": "4",
      "year": "2018"
    },
    {
      "DOI": "10.1002/cncr.31908",
      "author": "J Wu",
      "doi-asserted-by": "publisher",
      "first-page": "1060",
      "journal-title": "Cancer.",
      "key": "1448_CR24",
      "unstructured": "Wu J, Wang H, Ricketts CJ, Yang Y, Merino MJ, Zhang H, et al. Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease. Cancer. 2019;125:1060‚Äì9.",
      "volume": "125",
      "year": "2019"
    },
    {
      "DOI": "10.1002/cncr.32740",
      "author": "H Maynard",
      "doi-asserted-by": "publisher",
      "first-page": "1995",
      "journal-title": "Cancer",
      "key": "1448_CR25",
      "unstructured": "Maynard H, Stadler ZK, Berger MF, Solit DB, Ly M, Lowery MA, et al. Germline alterations in patients with biliary tract cancers: a spectrum of significant and previously underappreciated findings. Cancer 2020;126:1995‚Äì2002.",
      "volume": "126",
      "year": "2020"
    },
    {
      "DOI": "10.1111/pin.12977",
      "author": "A Shinozaki-Ushiku",
      "doi-asserted-by": "publisher",
      "first-page": "775",
      "journal-title": "Pathol Int",
      "key": "1448_CR26",
      "unstructured": "Shinozaki-Ushiku A, Kohsaka S, Kage H, Oda K, Miyagawa K, Nakajima J, et al. Genomic profiling of multiple primary cancers including synchronous lung adenocarcinoma and bilateral malignant mesotheliomas: Identification of a novel BAP1 germline variant. Pathol Int. 2020;70:775‚Äì80.",
      "volume": "70",
      "year": "2020"
    },
    {
      "DOI": "10.1158/2159-8290.CD-19-1220",
      "author": "M Carbone",
      "doi-asserted-by": "publisher",
      "first-page": "1103",
      "journal-title": "Cancer Discov",
      "key": "1448_CR27",
      "unstructured": "Carbone M, Harbour JW, Brugarolas J, Bononi A, Pagano I, Dey A, et al. Biological mechanisms and clinical significance of BAP1 mutations in human cancer. Cancer Discov. 2020;10:1103‚Äì20.",
      "volume": "10",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.cancergen.2021.03.007",
      "author": "Y Laitman",
      "doi-asserted-by": "publisher",
      "first-page": "31",
      "journal-title": "Cancer Genet",
      "key": "1448_CR28",
      "unstructured": "Laitman Y, Newberg J, Molho RB, Jin DX, Friedman E. The spectrum of tumors harboring BAP1 gene alterations. Cancer Genet. 2021;256‚Äì257:31‚Äì35.",
      "volume": "256‚Äì257",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41436-021-01172-3",
      "author": "DT Miller",
      "doi-asserted-by": "publisher",
      "first-page": "1381",
      "journal-title": "Genet Med",
      "key": "1448_CR29",
      "unstructured": "Miller DT, Lee K, chung WK, Gordon AS, Herman GE, Klein TE, et al. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23:1381‚Äì90.",
      "volume": "23",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.annonc.2022.12.003",
      "doi-asserted-by": "publisher",
      "key": "1448_CR30",
      "unstructured": "Kuzbari Z, Bandlamundi C, Loveday C, Garrett A, Mehine M, George A, et al. Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations. Ann Oncol Off J Eur Soc Med Oncol. 2022. https://doi.org/10.1016/j.annonc.2022.12.003."
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "journal-title": "Genet Med",
      "key": "1448_CR31",
      "unstructured": "Richards S, aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405‚Äì24.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1073/pnas.1821510116",
      "author": "R Hassan",
      "doi-asserted-by": "publisher",
      "first-page": "9008",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "1448_CR32",
      "unstructured": "Hassan R, Moroow B, Thomas A, Walsh T, Lee MK, Gulsuner S, et al. Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy. Proc Natl Acad Sci USA. 2019;116:9008‚Äì13.",
      "volume": "116",
      "year": "2019"
    },
    {
      "DOI": "10.1016/S0161-6420(96)30707-0",
      "author": "AD Singh",
      "doi-asserted-by": "publisher",
      "first-page": "256",
      "journal-title": "Ophthalmology",
      "key": "1448_CR33",
      "unstructured": "Singh AD, Shields CL, Shields JA, De Potter P. Bilateral primary uveal melanoma. Bad luck or bad genes? Ophthalmology. 1996;103:256‚Äì62.",
      "volume": "103",
      "year": "1996"
    },
    {
      "DOI": "10.1016/j.jfo.2015.04.003",
      "author": "M Nielsen",
      "doi-asserted-by": "publisher",
      "first-page": "516",
      "journal-title": "J Fr Ophtalmol",
      "key": "1448_CR34",
      "unstructured": "Nielsen M, Dogrus√∂z M, Bleeker JC, Kroes WG, van Asperen CA, Marinkovic M, et al. The genetic basis of uveal melanoma. J Fr Ophtalmol. 2015;38:516‚Äì21.",
      "volume": "38",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ajo.2020.12.005",
      "doi-asserted-by": "publisher",
      "key": "1448_CR35",
      "unstructured": "Singh N, Singh R, Bowen RC, Abdel-Rahman MH, Singh AD. Uveal melanoma in BAP1 tumor predisposition syndrome: estimation of risk. Am J Ophthalmol. 2020. https://doi.org/10.1016/j.ajo.2020.12.005"
    },
    {
      "DOI": "10.1016/j.jdcr.2020.04.018",
      "author": "KZ Young",
      "doi-asserted-by": "publisher",
      "first-page": "563",
      "journal-title": "JAAD Case Rep",
      "key": "1448_CR36",
      "unstructured": "Young KZ, Fossum SL, Lowe L, Else T, Fecher LA, Demirci A, et al. An adolescent with uveal melanoma and BAP1 tumor predisposition syndrome. JAAD Case Rep. 2020;6:563‚Äì6.",
      "volume": "6",
      "year": "2020"
    },
    {
      "DOI": "10.1016/S0161-6420(98)92205-9",
      "author": "AD Singh",
      "doi-asserted-by": "publisher",
      "first-page": "195",
      "journal-title": "Ophthalmology",
      "key": "1448_CR37",
      "unstructured": "Singh AD, De Potter P, Fijal BA, Shields CL, Shields JA, Elston RC. Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis. Ophthalmology. 1998;105:195‚Äì8.",
      "volume": "105",
      "year": "1998"
    },
    {
      "DOI": "10.3109/13816810.2015.1010734",
      "author": "CM Cebulla",
      "doi-asserted-by": "publisher",
      "first-page": "126",
      "journal-title": "Ophthalmic Genet",
      "key": "1448_CR38",
      "unstructured": "Cebulla CM, Binkley EM, Pilarski R, Massengill JB, Rai K, Liebner DA, et al. Analysis of BAP1 germline gene mutation in young uveal melanoma patients. Ophthalmic Genet. 2015;36:126‚Äì31.",
      "volume": "36",
      "year": "2015"
    },
    {
      "DOI": "10.1001/archophthalmol.2009.208",
      "author": "CL Shields",
      "doi-asserted-by": "publisher",
      "first-page": "989",
      "journal-title": "Arch Ophthalmol",
      "key": "1448_CR39",
      "unstructured": "Shields CL, Furuta M, Thangappan A, Nagori S, Mashayekhi A, Lally DR. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol. 2009;127:989‚Äì98.",
      "volume": "127",
      "year": "2009"
    },
    {
      "DOI": "10.3390/cancers13092267",
      "author": "RN Hussain",
      "doi-asserted-by": "publisher",
      "first-page": "2267",
      "journal-title": "Cancers (Basel)",
      "key": "1448_CR40",
      "unstructured": "Hussain RN, Coupland SE, Kalirai H, Taktak AFG, Eleuteri A, damato BE, et al. Small high-risk uveal melanomas have a lower mortality rate. Cancers (Basel). 2021;13:2267.",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1016/S0190-9622(86)70100-X",
      "author": "DS Rigel",
      "doi-asserted-by": "publisher",
      "first-page": "857",
      "journal-title": "J Am Acad Dermatol",
      "key": "1448_CR41",
      "unstructured": "Rigel DS, Friedman RJ, Kopf AW, Weltman R, Prioleau PG, safai B, et al. Importance of complete cutaneous examination for the detection of malignant melanoma. J Am Acad Dermatol. 1968;14:857‚Äì60.",
      "volume": "14",
      "year": "1968"
    },
    {
      "DOI": "10.1002/cncr.22050",
      "author": "AC Geller",
      "doi-asserted-by": "publisher",
      "first-page": "806",
      "journal-title": "Cancer",
      "key": "1448_CR42",
      "unstructured": "Geller AC, Emmons KM, Brooks DR, Powers C, Zhang Z, Koh HK, et al. A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer. 2006;107:806‚Äì14.",
      "volume": "107",
      "year": "2006"
    },
    {
      "DOI": "10.1111/bjd.12003",
      "author": "LJ Titus",
      "doi-asserted-by": "publisher",
      "first-page": "571",
      "journal-title": "Br J Dermatol",
      "key": "1448_CR43",
      "unstructured": "Titus LJ, Clough-Gorr K, Mackenzie TA, Perry A, Spencer SK, Weiss J, et al. Recent skin self-examination and doctor visits in relation to melanoma risk and tumour depth. Br J Dermatol. 2013;168:571‚Äì6.",
      "volume": "168",
      "year": "2013"
    },
    {
      "DOI": "10.21037/tlcr.2019.11.11",
      "author": "N Alpert",
      "doi-asserted-by": "publisher",
      "first-page": "S28",
      "journal-title": "Transl Lung Cancer Res",
      "key": "1448_CR44",
      "unstructured": "Alpert N, van Gerwen M, Taioli E. Epidemiology of mesothelioma in the 21st century in Europe and the United States, 40 years after restricted/banned asbestos use. Transl Lung Cancer Res. 2020;9:S28‚Äì38.",
      "volume": "9",
      "year": "2020"
    },
    {
      "DOI": "10.1093/carcin/bgu227",
      "author": "F Baumann",
      "doi-asserted-by": "publisher",
      "first-page": "76",
      "journal-title": "Carcinogenesis",
      "key": "1448_CR45",
      "unstructured": "Baumann F, Flores E, Napolitano A, Kanodia S, Taioli E, Pass H, et al. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis. 2015;36:76‚Äì81.",
      "volume": "36",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.jtho.2022.03.014",
      "author": "M Carbone",
      "doi-asserted-by": "publisher",
      "first-page": "873",
      "journal-title": "J Thorac Oncol",
      "key": "1448_CR46",
      "unstructured": "Carbone M, Pass HI, Ak G, Alexander HR Jr, Bass P, Baumann F, et al. Medical and surgical care of patients with mesothelioma and their relatives carrying germline BAP1 mutations. J Thorac Oncol. 2022;17:873‚Äì89.",
      "volume": "17",
      "year": "2022"
    },
    {
      "DOI": "10.1016/S1470-2045(12)70584-3",
      "author": "P Kapur",
      "doi-asserted-by": "publisher",
      "first-page": "159",
      "journal-title": "Lancet Oncol",
      "key": "1448_CR47",
      "unstructured": "Kapur P, Pe√±a-Llopis S, Christie A, Zhrebker L, Pav√≠a-Jim√©nez A, Rathmell WK, et al. Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation. Lancet Oncol. 2013;14:159‚Äì67.",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1200/JCO.19.02263",
      "author": "MW Ball",
      "doi-asserted-by": "publisher",
      "first-page": "1146",
      "journal-title": "J Clin Oncol",
      "key": "1448_CR48",
      "unstructured": "Ball MW, An JY, Gomella PT, Gautam R, Ricketts CJ, Vocke CD, et al. Growth rates of genetically defined renal tumors: implications for active surveillance and intervention. J Clin Oncol. 2020;38:1146‚Äì53.",
      "volume": "38",
      "year": "2020"
    },
    {
      "DOI": "10.3233/KCA-180028",
      "author": "TJ van Oostenbrugge",
      "doi-asserted-by": "publisher",
      "first-page": "79",
      "journal-title": "Kidney Cancer",
      "key": "1448_CR49",
      "unstructured": "van Oostenbrugge TJ, F√ºtterer JJ, Mulders PFA. Diagnostic imaging for solid renal tumors: a pictorial review. Kidney Cancer. 2018;2:79‚Äì93.",
      "volume": "2",
      "year": "2018"
    }
  ],
  "reference-count": 49,
  "references-count": 49,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-023-01448-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "31"
}